Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 2/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21392623 | 0.96 | SIGMAR1 (0.35) | PDK2SIGMAR1ALDH1A1HPGDTSHR | |
| SCHEMBL20762839 | 0.95 | PDK2 (0.33) | PDK2SIGMAR1 | |
| SCHEMBL19165668 | 0.93 | SIGMAR1 (0.35) | PDK2SIGMAR1ALDH1A1HPGDTSHR | |
| SCHEMBL19165443 | 0.93 | SIGMAR1 (0.35) | PDK2SIGMAR1ALDH1A1HPGDTSHR | |
| SCHEMBL19167386 | 0.93 | SIGMAR1 (0.35) | PDK2SIGMAR1ALDH1A1HPGDTSHR | |
| SCHEMBL23597862 | 0.93 | SIGMAR1 (0.35) | PDK2SIGMAR1ALDH1A1HPGDTSHR | |
| SCHEMBL808072 | 0.93 | SIGMAR1 (0.35) | PDK2SIGMAR1ALDH1A1HPGDTSHR | |
| SCHEMBL21141477 | 0.92 | KDM4E (0.34) | PDK2SIGMAR1 | |
| SCHEMBL19168676 | 0.92 | SIGMAR1 (0.33) | PDK2SIGMAR1 | |
| SCHEMBL23155331 | 0.92 | DNMT1 (0.33) | PDK2SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11512038-B2 | Tetraphenylene triarylamine compounds | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2022-11-29 | — | — | US | disclosed |
| US-20190185412-A1 | TETRAPHENYLENE TRIARYLAMINE COMPOUNDS | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2019-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11512038-B2 | Tetraphenylene triarylamine compounds | OCIAD2, OCIAD1, SLC7A5 | PDK2 2504/4885SIGMAR1 2169/4885ALDH1A1 2637/4885 |
| US-20190185412-A1 | TETRAPHENYLENE TRIARYLAMINE COMPOUNDS | OCIAD2, OCIAD1, SLC7A5 | PDK2 2504/4885SIGMAR1 2169/4885ALDH1A1 2637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.